Martha O'Neill

Martha joined Health Advances in 2012 and is an experienced team leader in the Diagnostics and Digital Health practices. She has extensive experience developing growth strategies for and conducting due diligence on innovative products and technologies across neurology, infectious disease, oncology, and women's health. Specific areas of expertise include commercialization strategy, opportunity assessment, portfolio prioritization, due diligence, and forecasting.

Apart from her time at Health Advances, Martha worked in the Office of the CEO at Foundation Medicine and has supported startups in the drug discovery and virtual care spaces with business development and commercialization strategy.

Martha earned an MBA from the Tuck School of Business at Dartmouth where she was a Tuck Scholar and a BA in Engineering Sciences and Biology, magna cum laude, from Dartmouth College.